Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T

Liuhong Zhu, Weihong Lu, Funan Wang, Yanwei Wang, Pu-Yeh Wu, Jianjun Zhou, Hao LiuBmc Medical Imaging 2023 · DOI

TL;DR

This study investigates the effectiveness of T2 mapping, a non-enhanced MRI technique, for quantifying and differentiating uterine lesions. The research demonstrates that T2 mapping performs better at 3.0 T compared to 1.5 T, particularly in distinguishing between benign and malignant uterine tumors, suggesting its potential as a valuable quantitative tool in gynecological imaging.

What Problem Does This Paper Address?

Diagnosing uterine lesions traditionally relies on radiologists' interpretation of MRI images, which can be subjective and dependent on image contrast. While MRI is a powerful tool, there's a growing need for objective, reproducible, and non-invasive quantitative methods. T2 mapping offers such a technique, providing quantitative information about tissue properties without the need for contrast agents. However, the influence of different magnetic field strengths (specifically the commonly used 1.5 T and 3.0 T) on T2 mapping's diagnostic performance for uterine lesions has not been systematically explored. This paper aims to fill that gap by comparing T2 mapping's ability to quantify and discriminate uterine lesions across these two field strengths.

Methods

The study employed a multi-echo spin-echo (MESE) method for T2 mapping, a technique chosen for its stability. T2 maps were generated by monoexponential fitting of signal intensity data acquired with multiple echo times. For healthy subjects, regions of interest (ROIs) were placed on normal uterine structures (endometrium, junctional zone, external-myometrium layer) and surrounding tissues (gluteus maximus, subcutaneous fat). For patients with suspected uterine lesions, ROIs were manually delineated on the maximum cross-section of the lesions, avoiding visible cystic necrosis. T2 values were then extracted from these ROIs. Statistical analysis involved comparing T2 values between different field strengths and lesion types using appropriate tests, and receiver operating characteristic (ROC) analysis was used to evaluate diagnostic efficacy.

Datasets

The study included data from:

  • 50 healthy subjects (age 36.7±5.9 years)
  • 126 patients with suspected uterine lesions, confirmed by pathology.

The lesions included:

  • Benign: Adenomyosis (n=21), Myoma (n=32), Endometrial polyps (n=28)
  • Malignant: Cervical cancer (n=23), Endometrial carcinoma (n=29)

This dataset represents a collection of uterine lesions and normal tissues analyzed using T2 mapping at both 1.5 T and 3.0 T MRI.

Key Insights and Ideas

  • Field Strength Matters: T2 values for both normal tissues and uterine lesions are consistently lower at 3.0 T compared to 1.5 T. This is a crucial observation for comparing studies across different field strengths.
  • T2 Mapping Differentiates Lesions: Significant differences in T2 values were observed between various benign and malignant uterine lesion subgroups, highlighting T2 mapping's potential for lesion characterization.
  • Superiority of 3.0 T for Discrimination: T2 mapping at 3.0 T demonstrated a significantly higher area under the curve (AUC) in differentiating benign from malignant lesions compared to 1.5 T. This suggests that higher field strength enhances the diagnostic performance of T2 mapping for this specific task.
  • Benign vs. Malignant Trend: Benign uterine lesions generally exhibited lower T2 values than malignant lesions across both field strengths, providing a quantitative basis for distinguishing between these categories.

Key Results

  • Lower T2 at Higher Field: Mean T2 values for all normal uterine structures and uterine lesions were significantly lower at 3.0 T than at 1.5 T (p < 0.05).
  • Lesion Subgroup Differences: Significant differences in T2 values were found between most lesion subgroups under both 1.5 T and 3.0 T MRI (p < 0.05).
  • Benign vs. Malignant T2 Values: Benign lesions had T2 values of 71.1 ± 22.0 ms at 1.5 T and 63.4 ± 19.1 ms at 3.0 T, while malignant lesions had T2 values of 101.1 ± 4.5 ms at 1.5 T and 93.5 ± 5.1 ms at 3.0 T.
  • Diagnostic Efficacy: The AUC for differentiating benign from malignant lesions was 0.902 at 1.5 T and significantly higher at 0.941 at 3.0 T (p = 0.02). Sensitivity and specificity were also comparable or slightly better at 3.0 T.

Limitations and Future Work

The authors acknowledge several limitations:

  • Healthy Subject Demographics: The healthy control group consisted only of women of childbearing age, limiting the generalizability of findings to other age groups.
  • Motion Artifacts: Motion artifacts, particularly in 3.0 T scans, influenced measurements and led to patient exclusions. Future work could explore motion-insensitive sequences or correction techniques.
  • Parameter Inconsistency: The acquisition parameters for T2 mapping sequences were not identical between the 1.5 T and 3.0 T scanners, which could affect T2 fitting variance. Future studies should aim for identical parameters to further validate the results.
  • Limited Malignant Tumor Classification: The study did not include all types of malignant uterine tumors (e.g., uterine sarcoma, choriocarcinoma) and did not further classify malignant tumors by pathological subtype. Future research could expand the scope to include a wider range of malignant lesions and detailed pathological subtyping.

Despite these limitations, the study lays a foundation for further quantitative research on uterine tumors using T2 mapping.

Summary updated

BibTeX
@article{zhu2023study,
  author = {Liuhong Zhu and Weihong Lu and Funan Wang and Yanwei Wang and Pu-Yeh Wu and Jianjun Zhou and Hao Liu},
  title = {{Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T}},
  journal = {Bmc Medical Imaging},
  year = {2023},
  doi = {10.1186/s12880-022-00960-w},
}
Figure